• Biocon Biologics Ltd has received marketing authorisation from the European Commission for its biosimilar YESINTEK®.
  • YESINTEK® is designed for treating plaque psoriasis, psoriatic art…

Unlock the Full Filing And Lot More

Access premium insights and stay ahead of the market with Dzambhala NodeX.

Try Now For Free
#BIOCON #Corporate Action

Join the vibrant privacy-ensured Dzambhala community on